214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRASG12D mutant cancer
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797629909139456000 |
|---|---|
| author | Nataliya Tovbis Shifrin Marie Menard Haley Courtney Swetha Ganesh Alice Kumamoto Lillian Seu Jacqueline AM Smith Elsa Quintana |
| author_facet | Nataliya Tovbis Shifrin Marie Menard Haley Courtney Swetha Ganesh Alice Kumamoto Lillian Seu Jacqueline AM Smith Elsa Quintana |
| author_sort | Nataliya Tovbis Shifrin |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:59:26Z |
| format | Article |
| id | doaj.art-a5e51eab63604e868847c92607d0e712 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:59:26Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-a5e51eab63604e868847c92607d0e7122023-11-12T15:00:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0214214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRASG12D mutant cancerNataliya Tovbis Shifrin0Marie Menard1Haley Courtney2Swetha Ganesh3Alice Kumamoto4Lillian Seu5Jacqueline AM Smith6Elsa Quintana7Revolution Medicines, Redwood City, CA, USARevolution Medicines, Redwood City, CA, USARevolution Medicines, Redwood City, CA, USARevolution Medicines, Redwood City, CA, USARevolution Medicines, Redwood City, CA, USARevolution Medicines, Redwood City, CA, USARevolution Medicines, Redwood City, CA, USARevolution Medicines, Redwood City, CA, USA |
| spellingShingle | Nataliya Tovbis Shifrin Marie Menard Haley Courtney Swetha Ganesh Alice Kumamoto Lillian Seu Jacqueline AM Smith Elsa Quintana 214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRASG12D mutant cancer Journal for ImmunoTherapy of Cancer |
| title | 214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRASG12D mutant cancer |
| title_full | 214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRASG12D mutant cancer |
| title_fullStr | 214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRASG12D mutant cancer |
| title_full_unstemmed | 214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRASG12D mutant cancer |
| title_short | 214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRASG12D mutant cancer |
| title_sort | 214 the krasg12d on covalent tricomplex inhibitor rm 044 increases tumor antigen presentation and tcr repertoire diversity to promote anti tumor immunity in a preclinical model of krasg12d mutant cancer |
| work_keys_str_mv | AT nataliyatovbisshifrin 214thekrasg12doncovalenttricomplexinhibitorrm044increasestumorantigenpresentationandtcrrepertoirediversitytopromoteantitumorimmunityinapreclinicalmodelofkrasg12dmutantcancer AT mariemenard 214thekrasg12doncovalenttricomplexinhibitorrm044increasestumorantigenpresentationandtcrrepertoirediversitytopromoteantitumorimmunityinapreclinicalmodelofkrasg12dmutantcancer AT haleycourtney 214thekrasg12doncovalenttricomplexinhibitorrm044increasestumorantigenpresentationandtcrrepertoirediversitytopromoteantitumorimmunityinapreclinicalmodelofkrasg12dmutantcancer AT swethaganesh 214thekrasg12doncovalenttricomplexinhibitorrm044increasestumorantigenpresentationandtcrrepertoirediversitytopromoteantitumorimmunityinapreclinicalmodelofkrasg12dmutantcancer AT alicekumamoto 214thekrasg12doncovalenttricomplexinhibitorrm044increasestumorantigenpresentationandtcrrepertoirediversitytopromoteantitumorimmunityinapreclinicalmodelofkrasg12dmutantcancer AT lillianseu 214thekrasg12doncovalenttricomplexinhibitorrm044increasestumorantigenpresentationandtcrrepertoirediversitytopromoteantitumorimmunityinapreclinicalmodelofkrasg12dmutantcancer AT jacquelineamsmith 214thekrasg12doncovalenttricomplexinhibitorrm044increasestumorantigenpresentationandtcrrepertoirediversitytopromoteantitumorimmunityinapreclinicalmodelofkrasg12dmutantcancer AT elsaquintana 214thekrasg12doncovalenttricomplexinhibitorrm044increasestumorantigenpresentationandtcrrepertoirediversitytopromoteantitumorimmunityinapreclinicalmodelofkrasg12dmutantcancer |